Fibrovera for Uterine and Hormonal Health
During the month of March, the healthcare community focuses its attention on raising awareness for Endometriosis, a disease that affects an estimated one in ten women worldwide. Endometriosis is one of many frustrating uterine issues that women suffer from that disrupt menstruation, fertility, reproductive function, and well-being. A number of health problems that women experience are linked to an imbalance in estrogen levels. Factors such as genetics, underlying ailments, diet, and even certain products that women frequently use such as oral contraceptives, makeup, and skin or hair care products can influence estrogen activity [1]. Various chemicals that are used to produce specific types of food can alter estrogen production as well [2].
A particularly burdensome issue linked to estrogen imbalance that many women struggle with is the excessive growth of fibrous tissue outside of the uterus [3]. Estrogen dominance, which refers to excessive amounts of estrogen, is quite common among women who are struggling with fibrin and fibrous protein tissue growth [3]. High estrogen levels subsequently cause additional hormonal imbalances (e.g., progesterone) that alter reproductive health and lead to persistent discomfort. In a desire to help women dealing with these issues, the experts at Arthur Andrew Medical developed Fibrovera, an all-natural blend of enzymes, herbs, vitamins, and minerals that supports women’s health. The ingredients in this nutritional supplement were chosen based on clinically-supported evidence that demonstrates their ability to help promote healthy estrogen levels while enhancing progesterone production [5-7].
Fibrovera also contains herbs such as black cohosh and don quai, which help target menstrual issues such as cramping, headaches, hot flashes, mood swings, and irritability due to their muscle-relaxing properties [13, 14].
Another product that supports healthy hormone levels for women dealing with issues related to estrogen dominance is Proferia, a topical progesterone cream. This high-quality cream heightens progesterone production in women who are experiencing frustrating uterine issues or menstrual difficulties due to hormonal imbalances. Research shows that topical progesterone can be efficiently absorbed through the skin and delivered to different parts of the body [15].
A number of women who have used Proferia cream have reported an improvement of menstrual complications, and those who did not experience the desired benefits often noticed improvement after adding Fibrovera to their diet. Therefore, both of these products offer women useful alternatives to hormone replacement approaches for common issues.
Overall, the specific blend of research-based ingredients in Fibrovera and Proferia help the body restore the proper balance of hormones naturally. They also support natural healing processes that can help women benefit from easier menstruation and fewer issues related to common uterine problems. Women who start taking Fibrovera and using Proferia regularly can experience long-term health benefits that truly heighten their quality of life.
References
- Wright PK, Johnson JV. Evaluation of extended and continuous use oral contraceptives. Ther Clin Risk Manag. 2008 Oct; 4(5): 905-911.
- Mnif W, et al. Effect of Endocrine Disruptor Pesticides: A Review. Int J Environ Res Public Health. 2011;8(6):2265-2303.
- Chantalat E, et al. Estrogen Receptors and Endometriosis. Int J Mol Sci. 2020;21(8):2815.
- Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL, Bjeldanes LF. Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr Cancer. 2004;50(2):161-7.
- Weissman A, Horowitz E, Ravhon A, Golan A, Levran D. Dehydroepiandrosterone supplementation increases baseline follicular phase progesterone levels. Gynecol Endocrinol. 2011;27(12):1014-1017.
- Spark MJ, Willis J. Systematic review of progesterone use by midlife and menopausal women. Maturitas. 2012; 72(3):192-202.
- de Ziegler D, Ferriani R, Moraes LA, Bulletti C. Vaginal progesterone in menopause: Crinone 4% in cyclical and constant combined regimens. Hum Reprod. 2000;15 Suppl 1:149-158.
- Saint-Criq V, Harvey BJ. Estrogen and the cystic fibrosis gender gap. Steroids. 2014;81:4-8.
- Hale LP, Greer PK, Sempowski GD. Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation. Clin Immunol. 2002;104:183-190.
- Smyth RD, Brennan R, Martin GJ. Systemic biochemical changes following the oral administration of a proteolytic enzyme, bromelain. Arch Int Pharmacodyn. 1962;136:230-236.
- Leipner J, Iten F, Saller R. Therapy with proteolytic enzymes in rheumatic disorders. BioDrugs. 2001;15(12):779-789.
- Leipner J, Saller R. Systemic enzyme therapy in oncology: effect and mode of action. Drugs. 2000;59(4):769-780.
- Johnson TL, Fahey JW. Black cohosh: coming full circle? 2012;141(3):775-9.
- Raus K, Brucker C, Gorkow C, Wuttke W. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055. Menopause 2006;13:678-91.
- Spark MJ, Willis J. Systematic review of progesterone use by midlife and menopausal women. Maturitas. 2012; 72(3):192-202.